STRS Ohio’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

STRS Ohio’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,200	Closed	-$649K	–	2339
2021 Q3	$649K	Buy	32,200 +500	+2%	+$13.8K	﹤0.01%	1401
2021 Q2	$1.18M	Sell	31,700 -9,600	-23%	-$294K	﹤0.01%	1072
2021 Q1	$1.06M	Hold	41,300	–	–	﹤0.01%	1131
2020 Q4	$909K	Sell	41,300 -1,700	-4%	-$37.4K	﹤0.01%	1122
2020 Q3	$773K	Buy	43,000 +7,800	+22%	+$162K	﹤0.01%	1078
2020 Q2	$894K	Sell	35,200 -4,900	-12%	-$106K	﹤0.01%	949
2020 Q1	$736K	Buy	40,100 +6,000	+18%	+$117K	﹤0.01%	863
2019 Q4	$751K	Buy	+34,100	New	+$686K	﹤0.01%	1122
2015 Q3	–	Sell	-16,800	Closed	-$194K	–	1965
2015 Q2	$234K	Buy	+16,800	New	+$308K	﹤0.01%	1528

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

STRS Ohio's DRNA Position: Q4 2021 in Review

STRS Ohio sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 32,200 shares — an estimated $649K sold.

STRS Ohio first reported a position in DRNA in Q2 2015 and held it in 9 quarters. The position peaked at $1.18M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

STRS Ohio reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
STRS Ohio sold 32,200 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $649K.
STRS Ohio first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2015 and held it in 9 quarters.
STRS Ohio's Dicerna Pharmaceuticals, Inc. position peaked at $1.18M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on STRS Ohio's 13F filing for Q4 2021, filed 24 Jan 2022.